Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy

J Immunol Res. 2023 Nov 9;2023:5599660. doi: 10.1155/2023/5599660. eCollection 2023.ABSTRACTThe clinical efficacy of surgery, radiotherapy, and chemotherapy for cancer is usually limited by the deterioration of tumor microenvironment (TME). Neutrophil extracellular traps (NETs) are decondensed chromatin extruded by neutrophils and are widely distributed among various cancers, such as pancreatic cancer, breast cancer, and hepatocellular carcinoma. In the TME, NETs interact with stromal components, immune cells and cancer cells, which allows for the reshaping of the matrix and the extracellular environment that favors the initiation, progression, and metastasis of cancer. In addition, NETs impair the proliferation and activation of T cells and NK cells, thus producing a suppressive TME that restricts the effect of immunotherapy. A better understanding of the function of NETs in the TME will provide new opportunities for the prevention of cancer metastasis and the discovery of novel therapy strategies.PMID:38023616 | PMC:PMC10653965 | DOI:10.1155/2023/5599660
Source: Journal of Immunology Research - Category: Allergy & Immunology Authors: Source Type: research